For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Valeant Pharmaceuticals International

USPTO Granted Patents = 22

CIPO Patents = 2

EPO Patents = 6

Trademarks = 45

Forward Citations = 88

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Jean-Michel Andre Vernier (12 out of 56 patents)

Huanming Chen (11 out of 15 patents)

Jim Zhen Wu (6 out of 11 patents)

4. Jianlan Song (6 out of 6 patents)

5. Martha Alicia De La Rosa (4 out of 24 patents)

6. Valery Rubinchik (2 out of 12 patents)

7. Charles Richard Kjellbotn (2 out of 5 patents)

8. Greg Heacock (2 out of 2 patents)

9. Louise Culham (2 out of 7 patents)

10. Wes A Williams (2 out of 2 patents)

11. Ni'Kita Wilson (2 out of 5 patents)

12. Gary Lee Larson (2 out of 2 patents)

13. Ian Wayne Cheney (2 out of 2 patents)

14. Irwin Palefsky (2 out of 5 patents)

15. Nikolaos Loupis (1 out of 47 patents)

22 patents: Sort by Forward Citations

1. 9949877 - Photodynamic therapy laser (2018-04-24),

2. 9655829 - Compositions and methods for teeth whitening (2017-05-23),

3. 9226917 - Photodynamic therapy for conditions of the eye (2016-01-05),

4. 9211214 - Photodynamic therapy laser (2015-12-15),

5. 8993593 - N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators (2015-03-31),

6. 8859618 - Silicone gel-based compositions for wound healing and scar reduction (2014-10-14),

7. 8852629 - Drug delivery system for hydrophobic drugs (2014-10-07),

8. 8722929 - N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators (2014-05-13),

9. 8563604 - Silicone gel-based compositions for wound healing and scar reduction (2013-10-22),

10. 8563566 - Naphthyridine derivatives as potassium channel modulators (2013-10-22),

11. 8492588 - Benzyloxy anilide derivatives useful as potassium channel modulators (2013-07-23),

12. 8367684 - Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators (2013-02-05),

13. 8338487 - [object Object] (2012-12-25),

14. 8293911 - Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators (2012-10-23),

15. 8211918 - Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators (2012-07-03),

Valeant Pharmaceuticals International is a multinational specialty pharmaceutical company. They develop, manufacture, and market a wide range of pharmaceutical products that improve people's lives. With a focus on dermatology, neurology, and eye care, Valeant is committed to delivering innovative and effective treatments to patients around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#19 in Bridgewater, NJ

#585 in New Jersey

#14,534 in US

#27,908 in the World

Bridgewater, NJ, United States of America

Valeant Pharmaceuticals International

Forward Citations = 88

26 inventors:

Jean-Michel Andre Vernier (12 out of 56 patents)

Huanming Chen (11 out of 15 patents)

Jim Zhen Wu (6 out of 11 patents)

4. Jianlan Song (6 out of 6 patents)

5. Martha Alicia De La Rosa (4 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…